Vivos Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · +1.86%
- Market cap
- $3.16M
- 33.82M shares
- Filings
- 303
Q3 2026+16.0% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−67.6% FY25 yoy
- $3.16M
- —
- 0.2×
- 1.3×
- -575.89%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $17,443,000 | reported | |
| FY 2024 | 2024-12-31 | $15,031,000 | reported | |
| FY 2023 | 2023-12-31 | $13,801,000 | reported | |
| FY 2022 | 2022-12-31 | $16,024,000 | reported | |
| FY 2021 | 2021-12-31 | $16,885,000 | reported | |
| FY 2020 | 2020-12-31 | $13,066,000 | reported | |
| FY 2019 | 2019-12-31 | $11,393,277 | reported |
Segments
Products
LineFY2025ShareChange
Sleep Testing Services$6.04M35%+371.2%
Appliances$3.28M19%−41.5%
Tooth Positioners$3.21M18%+41.2%
Treatment Centers$2.18M12%—
Sponsorship Seminar Other$1.22M7.0%−37.0%
Billing Intelligence Services$686.00K3.9%−18.3%
VIP$491.00K2.8%−80.2%
Other$337.00K1.9%−88.3%
Total$17.44M
Surgical & medical instruments & apparatus
Vivos Therapeutics, Inc. is the 82nd largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
BDMDBaird Medical Investment Holdings Ltd$22.5M39.2%121.0%$4.3MDRIODarioHealth Corp.$22.4M17.3%186.6%$41.2MMDAISpectral AI, Inc.$19.7M33.6%38.5%$43.6MSNOASonoma Pharmaceuticals, Inc.$19.5M36.7%16.3%$6.3MNEPHNephros Inc$18.8M32.7%6.4%$35.5M
VVOSVivos Therapeutics, Inc. (this company)$17.4M16.0%121.4%$3.2M
PROFProfound Medical Corp.$16.1M65.3%264.4%$270.7MBTCYBiotricity Inc.$16.0M16.0%15.0%$1.1MPLSMPulsenmore Ltd.$12.5M—39.6%$9.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Vivos Therapeutics, Inc. · CIK 1716166 · Engraved from SEC EDGAR